Shetty Ravi Dyavar, PhD

Shetty Ravi Dyavar, PhD has a comprehensive background in virology and immunology research. From 2008 to 2014, they served as a Postdoctoral Fellow in Immunology at Emory University, where they evaluated the effectiveness of immunotherapy for retroviral infection. During this time, they published research papers on this topic.

In 2014, Dyavar joined the University of Nebraska as a Research Instructor in Virology. In this role, they managed a team of postdoctoral fellows and graduate students to develop cell-based assays and support the development of therapies for retroviral infections. Shetty Ravi also developed a human primary lymphoid endothelial cell-based assay to determine the efficacy of antiviral drugs in crossing the lymphoid tissue barrier.

In 2017, they were promoted to Assistant Professor (Research) in Virology at the University of Nebraska. In this role, they continued to manage a team of scientists and developed virology and immunology assays to support the development of novel therapies for retroviral infection. Shetty Ravi notably developed ddPCR assays to normalize drug levels associated with T cells and mononuclear cells.

Since January 2021, Dyavar has been working at Adicet Bio, Inc as a Senior Scientist, initially as a Cell Therapy and Analytical Assay Development Lead, and later as a Senior Scientist II. In these roles, they have focused on analytical assay development for cell therapy. Further details regarding their work at Adicet Bio, Inc are not provided in the structured information.

Shetty Ravi Dyavar, PhD, began their education in 1995 at Osmania University, where they earned a Bachelor's degree in Biology. In addition to their biology degree, they also obtained a Bachelor's degree in Education during the same period. Continuing their studies, Dyavar pursued a Master's degree in Biochemistry at the University of Hyderabad from 1999 to 2001. Building on their previous qualifications, they then enrolled at Savitribai Phule Pune University, where they completed their Doctor of Philosophy (PhD) in Virology from 2002 to 2008.